Price (delayed)
$3.33
Market cap
$227.55M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.2
Enterprise value
$89.5M
Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of targeted therapies for women’s cancers. Its lead product candidate, OP-1250, is
There are no recent dividends present for OLMA.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from and Sharadar.